Adtalem Global Education (NYSE:CVSA) SVP Sells $614,676.06 in Stock

Adtalem Global Education Inc. (NYSE:CVSA) SVP Douglas Beck sold 4,526 shares of the business’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $135.81, for a total transaction of $614,676.06. Following the completion of the transaction, the senior vice president directly owned 28,544 shares of the company’s stock, valued at approximately $3,876,560.64. This represents a 13.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

Shares of CVSA stock traded down $2.73 during trading hours on Tuesday, reaching $125.98. 329,097 shares of the company were exchanged, compared to its average volume of 372,013. Adtalem Global Education Inc. has a fifty-two week low of $86.97 and a fifty-two week high of $156.26. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.09 and a current ratio of 1.09. The business has a fifty day moving average price of $124.82. The firm has a market cap of $4.29 billion, a P/E ratio of 17.89, a price-to-earnings-growth ratio of 1.05 and a beta of 0.62.

Adtalem Global Education (NYSE:CVSA) last posted its quarterly earnings data on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.19. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. The firm had revenue of $501.38 million during the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. On average, research analysts anticipate that Adtalem Global Education Inc. will post 8.95 earnings per share for the current year.

Analyst Upgrades and Downgrades

CVSA has been the subject of a number of recent research reports. Wall Street Zen upgraded Adtalem Global Education from a “hold” rating to a “buy” rating in a research report on Saturday. Truist Financial raised their price target on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, May 11th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Finally, Barrington Research reissued an “outperform” rating and set a $170.00 price objective on shares of Adtalem Global Education in a report on Monday, June 8th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.